• Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
Search
Medicines Law & Policy Research and resources on intellectual property and health
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About

Medicines Law & Policy

19 POSTS 0 COMMENTS

The European Commission says Covid-19 vaccines should be global public goods, but do their...

Medicines Law & Policy - January 28, 2021

Wrapping up 2020 with some noteworthy medicines, law and policy events

Medicines Law & Policy - December 29, 2020

COVID-19 Technology Access Pool (C-TAP): A Promising Human Rights Approach

Medicines Law & Policy - June 18, 2020

Medicines Law & Policy welcomes WHO’s Solidarity Call to Action to realise equitable global...

Medicines Law & Policy - May 29, 2020

Watch the webinar on the WHO Covid-19 Technology Pool

Medicines Law & Policy - May 15, 2020

Drug Price Transparency Calls Move from South Africa to World Health Assembly

Medicines Law & Policy - May 18, 2019

WHO Fair Pricing Forum: Watching for Drug Industry Accountability

Medicines Law & Policy - April 11, 2019

Medicines Law & Policy expert wins Prescrire Prize for “major reference work” on IP...

Medicines Law & Policy - October 5, 2017

“The diseases were in the South and the drugs were in the North”: Ellen...

Medicines Law & Policy - July 7, 2017
12Page 2 of 2
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
 This work is licensed under Creative Commons.